细胞化酶PADI4和转录抑制剂RING1B在癌细胞中结合
Salome Araujo-Abad1, Bruno Rizzuti2, Lourdes Soto-Conde3
1Cancer Research Group, Faculty of Engineering and Applied Sciences, Universidad de Las Américas, 170124 Quito, Ecuador; IDIBE, Universidad Miguel Hernández, 03202 Elche (Alicante), Spain.
International journal of biological macromolecules
|June 15, 2024
概括
研究人员发现,PADI4和RING1B蛋白在癌细胞中相互作用. 这种由GSK484抑制的相互作用表明,潜在的新型癌症疗法可以针对这种蛋白质结合.
科学领域:
- 表观遗传学和分子瘤学
背景情况:
- 聚合组 (PcG) 蛋白质,如RING1B (E3无素蛋白联酶),在发育和癌症中是至关重要的转录抑制剂.
- PADI4是一种将氨酸转化为氨酸的酶,涉及质母细胞瘤和其他癌症.
研究的目的:
- 为了研究癌症细胞系中PADI4和RING1B之间的物理联系.
- 探索PADI4-RING1B相互作用的功能影响和潜在的治疗相关性.
主要方法:
- 免疫光和近距离结合测试检测癌细胞中的PADI4-RING1B关联.
- 生物化学和生物物理技术,包括异热定位热量计 (ITC),核磁共振和光分析.
- 使用GSK484.4.的蛋白质-蛋白质对接模拟和酶抑制研究.
主要成果:
- 发现PADI4和RING1B在各种癌症细胞系的细胞核和细胞质中结合在一起.
- PADI4抑制剂GSK484显著降低了PADI4和RING1B之间的结合.
- 蛋白质-蛋白质对接和体外实验证实了PADI4与RING1B的N-终端和C-终端区域之间的结合,解离常数处于低微分子范围.
结论:
- RING1B与PADI4直接相互作用,可能是在其活性部位,这种相互作用可以通过PADI4抑制剂进行调节.
- 观察到的相互作用可能导致RING1B的素化,并可能产生下游生物后果.
- 这种PADI4-RING1B相互作用代表了改善癌症治疗策略的潜在治疗目标.
相关概念视频
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K


